The recommended zoledronic acid dose for treating high blood calcium due to cancer (known medically as hypercalcemia of malignancy) is 4 mg as a single dose. However, your healthcare provider may recommend a lower zoledronic acid dose if you have decreased kidney function. Your healthcare provider should check your kidney function (using a simple blood test) before your zoledronic acid dose. If necessary, you may need to be retreated with zoledronic acid if you do not fully respond to the medication (if your blood calcium does not return to normal). In this case, there should be at least seven days between doses.

 

Zometa (not Reclast) is the form of zoledronic acid that should be taken for this use.

 

Zoledronic acid is also used to prevent bone problems (such as broken bones) in people with cancer. For this use, the recommended dose is zoledronic acid 4 mg every three to four weeks. Your healthcare provider should measure your kidney function (using a simple blood test) before each dose and should adjust your dose as necessary. People with decreased kidney function need lower dosages.

 

Zometa (not Reclast) is the form of zoledronic acid that should be taken for this use.